GR LIFE STYLE (00108) announced that on January 26, 2026, the company entered into a strategic cooperation memorandum of understanding (MOU) with Wise Medical Technology (Shanghai) Co., Ltd. Pursuant to the MOU, the company and Wise Medical have initially agreed to integrate their core resources, using artificial intelligence technology as a link to deeply cultivate the fields of oncology real-world research and innovative research and development in traditional Chinese medicine, jointly promoting the deep integration and industrial upgrading of the "healthcare + technology + scenarios" model. The Group intends to leverage Wise Medical's technological and resource advantages to meet its current development needs for transitioning from a traditional property and asset management business into a digital AI technology healthcare services enterprise, thereby enhancing the diversity of the Group's business and creating future profit growth points. Specific areas of cooperation include, but are not limited to: jointly building a full-link digital marketing and health management system for pharmaceutical companies; and jointly establishing a digital clinical trial collaboration platform. Concurrently, the Group can utilize its own capital market strengths to engage in deeper cooperation with Wise Medical, and through the company's brand effect, drive the market promotion and further expansion of related cooperative business projects. Following the execution of the MOU, both parties will conduct relevant market analysis and industry research for the digital AI technology healthcare services enterprise, and will commence personnel communication and on-site inspection work as soon as possible. The Group has two reportable operating segments, including the Property Management segment; and the Property Development and Investment segment. The first segment operates in China, while the second segment operates in China, the United States of America, and the United Kingdom. While continuing to expand the Property Management and Property Development and Investment segments, the Group has also been exploring potential business opportunities aimed at diversifying its operations, broadening its revenue sources, and ultimately maximizing shareholder returns. The Directors believe that the signing of the strategic cooperation MOU with Wise Medical will be beneficial for the Group's development needs in transitioning from traditional property and asset management to a digital AI technology healthcare services enterprise. This business activity is expected to enhance the Group's financial performance and profitability, aligning with the overall interests of the company and its shareholders.